REN and hydrops fetalis: However, in stable HF patients treated with guideline-directed medical therapy (GDMT) such as renin–angiotensin system inhibitors (RASis), beta-blockers, and mineralocorticoid receptor antagonists (MRAs), the renal, hemodynamic, and neuroendocrine responses to alterations in sodium intake did not differ from those observed in healthy individuals [24].